Eur J Nucl Med. 1994 May;21(5):432-6.

The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.

Source

Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung Taiwan, Republic of China.

Abstract

Thirty-eight female patients (age range: 31-79 years) with breast masses underwent technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) breast scintigraphy in order to assess the value of this technique in the detection of breast carcinomas and in their differentiation from benign breast masses. The results showed that 27 of the 32 cases of breast carcinoma were detected by 99mTc-MIBI breast scintigraphy. In contrast, none of the six benign lesions could be detected by this method. The diagnostic sensitivity, specificity and accuracy were 84%, 100% and 87%, respectively, in the differentiation of malignant and benign breast masses. In conclusion, we consider 99mTc-MIBI breast scintigraphy is useful in distinguishing malignancies from benign breast masses.

PMID:: 8062849; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Technetium Tc 99m Sestamibi

LinkOut - more resources

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women. [Anticancer Res. 2000]
The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH. Anticancer Res. 2000 May-Jun; 20(3B):2133-6.
99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI. [Eur J Nucl Med. 2001]
99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Stipsanelli A, Louvrou A, Lazaris D, Sotiropoulou M, Pampouras G, Keramopoulos A, et al. Eur J Nucl Med. 2001 Jul; 28(7):923-8.
Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. [Nucl Med Commun. 1994]
Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography.
Burak Z, Argon M, Memiş A, Erdem S, Balkan Z, Duman Y, Ustün EE, Erhan Y, Ozkiliç H. Nucl Med Commun. 1994 Aug; 15(8):604-12.
Review Dynamic imaging: scintimammography. [Eur J Radiol. 1998]
Review Dynamic imaging: scintimammography.
Salvatore M, Del Vecchio S. Eur J Radiol. 1998 May; 27 Suppl 2:S259-64.
Review [The role of 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer]. [Orv Hetil. 1998]
Review [The role of 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer].
Ambrus E, Ormándi K, Séra T, Tószegi A, Csernay L, Pávics L. Orv Hetil. 1998 Jan 25; 139(4):183-7.

See reviews... See all...

Cited by 2 PubMed Central articles

FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis. [J Cancer Res Clin Oncol. 2010]
FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.
Pan L, Han Y, Sun X, Liu J, Gang H. J Cancer Res Clin Oncol. 2010 Jul; 136(7):1007-22. Epub 2010 Jan 21.
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. [Breast Cancer Res. 2005]
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, et al. Breast Cancer Res. 2005; 7(1):R33-45. Epub 2004 Nov 8.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evalu...
The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.
Eur J Nucl Med. 1994 May ;21(5):432-6.

PubMed
Reversal of chloroquine resistance in falciparum malaria by some calcium channel...
Reversal of chloroquine resistance in falciparum malaria by some calcium channel inhibitors and optical isomers is independent of calcium channel blockade.
Drug Chem Toxicol. 1994 ;17(2):149-62.

PubMed
Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency.
Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency.
Ann Hum Genet. 1975 Jan ;38(3):327-31.

PubMed
Calreticulin is released from activated neutrophils and binds to C1q and mannan-...
Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein.
Clin Immunol Immunopathol. 1994 Sep ;72(3):405-9.

PubMed
Improved description of the migraine aura by a diagnostic aura diary.
Improved description of the migraine aura by a diagnostic aura diary.
Cephalalgia. 1994 Apr ;14(2):107-17.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: